Status:
COMPLETED
The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori
Lead Sponsor:
Shandong University
Conditions:
Helicobacter Pylori Infection
Helicobacter Pylori Eradication
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In this study, effects of oral and written education, WeChat education plus oral and written education on Helicobacter pylori eradication will be compared in a randomized way.
Detailed Description
There are two randomized parallel groups in this study, control group and Wechat group.All of the patients will be treated with Amoxicillin + Clarithromycin + Bismuth + Vonoprazan fumarate. In control...
Eligibility Criteria
Inclusion
- aged between 18 and 75 years old;
- H. pylori infection confirmed by any two positive outcomes of rapid urease test (RUT), 13C-urea breath test (UBT) or histopathology.
Exclusion
- previous therapy for H. pylori;
- with significant underlying disease (e.g. decompensated liver cirrhosis, renal failure or malignant tumors) that may interfere the study;
- history of gastric surgery,
- pregnancy or lactation;
- the use of PPI or antibiotics during the 4 weeks prior to enrolment;
- previous history of allergic reactions to any of the medications used in this protocol;
- unable to use smartphone and wechat
- unwilling or incapable to provide informed consents.
Key Trial Info
Start Date :
July 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2022
Estimated Enrollment :
438 Patients enrolled
Trial Details
Trial ID
NCT04850209
Start Date
July 23 2021
End Date
September 10 2022
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu hosipital
Jinan, Shandong, China, 257000